Home » Newsletters » BioWorld Science

BioWorld Science

April 13, 2012

View Archived Issues

New vaccine shows promise to treat drug addiction

Santaris Pharma identifies new candidate gene therapies for cancer

Novel antibacterials presented by MicuRx Pharmaceuticals

U.S. university patents new histone demethylase inhibitors

Anacor develops novel antibacterial and antimycobacterial agents

New potential therapies for HIV infection reported by Roche

Investigation at Novartis yields novel ENaC antagonists

Novel PFK/FBPase inhibitors divulged by Kancera

Zannan and AB Pharma develop novel highly potent HCV NS3/NS4A inhibitor

Small ApoA-I mimetic is atheroprotective and can be used to image atherosclerotic plaques

New potential oral cancer therapy developed in Korea

Novel thiazolidinediones created in Brazil

Promising first clinical results reported on Affimed TandAb

Veles Pharma prepares innovative drugs for launch

Effective antiviral biosimilar immunotherapy produced by iBioLaunch technology

Arteriocyte obtains FDA clearance for compartment syndrome trial

Joint research for metabolic disease therapies advances

Bayer HealthCare submits new MAA for Xarelto

Agreement seeks to develop companion diagnostic for Adcetris

Novel anti-infectives disclosed by State University of New Jersey

AnGes and BioLeaders enter agreement on oral vaccine for hypertension

Alchemia provides update on pivotal HA-irinotecan trial

AstraZeneca and DNDi enter drug screening collaboration

Shire signs new acquisition agreement

OPKO Health kicks off phase III program for rolapitant

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...